Pharmabiz
 

3,900 new brands foray Indian pharma market during June 2002-04

Our Bureau, MumbaiTuesday, November 9, 2004, 08:00 Hrs  [IST]

During the last two years beginning from June 2002 to June 2004 the Indian pharmaceutical market had around 3,900 new brand introductions. According to Org-Ims retail audit new pharmaceutical products worth Rs 1580 crore have been launched in the country during this period. These products currently contribute an average of 8 per cent to the value of the entire retail market for ethical pharmaceutical drugs across the Indian sub-continent, a report released by ORG-IMS stated. In specific categories the contribution of new products assumes a sizeable proportion. Blood products and vaccines have registered a contribution of 17 per cent from new products in value terms. The categories that saw the maximum number of new product introductions were Anti-infectives (559), Gastro-intestinals (550) and Pain/Analgesics (495). Companies like Cipla, Micro, Lupin and Intas have launched the maximum number of new products over the last two years. Other Indian pharmaceutical players too have benefited from this trend. Sun pharma and Aristo for instance, have garnered more than Rs 10 million per new product, the release says. Some companies appear to have chosen a more aggressive new product launch strategy than others. Companies like Mankind pharma now earns almost a fourth of its turnover from brands launched in the last two years.

Table 1: Companies active in New Launches
Company Value in Rs. Million No. of new products Value per new product in Rs. Million
All companies 15785 3900 405
 Ranbaxy 861 117 736
Sun Pharma 821 78 1053
Nicholas Piramal 694 81 857
Cipla 597 190 314
Mankind 517 52 994
Aristo pharma 497 46 1080
Lupin Labs 493 139 355
Micro Labs 422 142 297
Intas 393 133 295
Shreya Life Sciences 381 83 459

Source: ORG-IMS Market Intelligence Report

Table 2: Top 10 New products
Brands Company Group Value in Rs. Million
Nurokind Mankind Vit.B12 and Metabolites 190
Asomex Emcure S-Amlodipine (plain & combination) 101
Rejunuron Fourrts Vit.B12 and Metabolites 98
Valus Glenmark Valdecoxib 89
Meganeuron Aristo Vit.B12 and Metabolites 88
Nervup Nicholas Vit.B12 and Metabolites 82
Mahacef Mankind Cefixime 81
Glycomet U.S.V Glimepiride+Metformine 80
Vah Nicholas Valdecoxib 80
Vibact U.S.V Lactic acid fermentors 80
Source: ORG-IMS Market Intelligence Report

 
[Close]